从2012年到2021年对肝细胞癌的跨动脉化学栓塞的研究趋势进行映射:2021年 - - 圣经识别分析
Na Zhang1, Xiao-Feng He2, Xiang-Ke Niu3,4
1Department of General Practice, Affiliated Hospital of Chengdu University, Chengdu 610081, Sichuan Province, China.
World journal of methodology
|September 29, 2023
概括
这份图书统计分析揭示了全球越来越多的关于肝细胞癌 (HCC) 通过导管动脉化学栓塞 (TACE) 的研究. 主要趋势包括专注于治疗预测和HCC研究的国际合作.
科学领域:
- 肝胆道医学 肝胆道医学
- 干预性放射学 干预性放射学
- 瘤学研究研究
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
- 过导管动脉化学栓塞 (TACE) 是HCC的主要治疗方法.
- 了解TACE研究趋势对于推进HCC治疗至关重要.
研究的目的:
- 分析和可视化TACE对HCC的科学成果.
- 确定TACE治疗HCC的研究趋势,合作和新兴主题.
主要方法:
- 在2012-2021年期间,利用科学网数据库对5728篇文章进行了图书统计分析.
- 使用VOSviewer和CiteSpace软件进行趋势分析,协作映射和关键字共发生分析.
- 检查出版量,国家/机构/作者生产力,期刊影响力和关键词/参考网络.
主要成果:
- 观察到TACE对HCC的出版物持续增加.
- 中国在文章量方面处于领先地位,而美国的引用量和希尔什指数最高.
- 国际合作正在增加",预测TACE治疗"被确定为研究热点.
结论:
- 图书统计分析突出了TACE对HCC的当前趋势和关键研究领域.
- 这些发现提供了对HCC治疗不断变化的景观的见解.
- 未来的研究可能会从专注于预测模型和国际合作中受益.
更多相关视频
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
10.4K
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
494
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K